Streetbeat News

Stock Prices

BF/A

BF/B

Brown Forman shares are trading higher following Q4 earnings.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:52 pm

CRKN

Crown Electrokinetics shares are trading lower following the announcement of an offering of 300 million shares of its common stock by Keystone Capital Partners.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:50 pm

GWAV

Greemwabe Technology Solutions shares are trading higher after the company announced record revenues for its downstream processing system in May 2024 and reaffirmed its confidence in exceeding its revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:48 pm

LQR

LQR House shares are trading higher after the company reported May revenues of $218,146.34, a significant increase from $40,825 last year.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:48 pm

SGRP

SPAR Group shares are trading lower after the company announced that it entered into a letter of intent to go private with Highwire Capital.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:45 pm

ZH

Zhihu has received a letter from the NYSE indicating that it has regained compliance with the NYSE ADS trading price requirement.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:44 pm

SILO

Silo Pharma shares are trading lower following the announcement of a $2 million registered direct offering.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:41 pm

ADIL

Adial Pharmaceuticals shares are trading higher after the company announced that the first patient has been dosed in its pharmacokinetics study of AD04 for Alcohol Use Disorder.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:40 pm

ICE

Intercontinental Exchange (ICE) reported a 33% year-over-year increase in average daily volume for May. This significant growth indicates strong performance and increased market activity.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:39 pm

GCTK

Glucotrack has completed its second long-term preclinical study for its continuous blood glucose monitor, showing a mean absolute relative difference of 4.7% at day 90.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:38 pm